For most of its history creatine lived in the same conversation as protein powder and pre workout. It was a gym supplement. People in lifting communities took it because the evidence on muscle and strength gains has been solid for thirty years. Almost everyone outside that crowd thought of it as something only bodybuilders cared about. That has changed in 2026 in a way that the supplement industry has been quietly preparing for. The mainstream conversation about creatine now includes brain function, women's health, and aging, and the research that pushed the conversation forward keeps coming.
The most cited new study is the CONCRET MENOPA trial, published this spring in the Journal of the American Nutrition Association. The eight week randomized controlled trial enrolled 36 perimenopausal and menopausal women with a mean age of 50 and assigned them to one of four arms. Low dose creatine hydrochloride at 750 milligrams per day, medium dose at 1500 milligrams per day, a creatine ethyl ester combination at 800 milligrams per day, or a placebo. The medium dose group showed significantly improved reaction time, a 16.4 percent increase in frontal brain creatine levels measured by MRI spectroscopy, and a favorable shift in serum lipids. The low dose and combination arms showed smaller but consistent benefits.
The reason the women's research matters is that women have 70 to 80 percent lower endogenous creatine stores than men. That biological gap has been documented for years but rarely translated into supplement guidance because almost all the research subjects in the early creatine studies were male athletes. The newer research suggests that the therapeutic window for creatine in women may actually be broader than in men, particularly during perimenopause and menopause when natural creatine production drops further. Five out of six recent studies on creatine and cognition in older adults have shown positive effects, with the strongest signals in memory and attention.
The brain effects are the part that has gotten the most popular press attention. Creatine plays a role in cellular energy metabolism in the brain the same way it does in muscle. Cells use phosphocreatine to rapidly regenerate ATP, which is the energy currency the brain runs on. Under conditions of sleep deprivation, mental fatigue, or aging, the brain's ability to keep up with ATP demand declines. Supplementing creatine appears to bolster that buffer system. A 2024 study published in Scientific Reports showed that a single high dose of creatine improved cognitive performance and changed measurable brain energy phosphate levels in subjects who had been sleep deprived.
The dosing conversation has also shifted. The old guidance was a five gram per day maintenance dose after a loading week of 20 grams per day for five days. That dosing was designed around muscle saturation. Newer research suggests that brain creatine levels rise more slowly than muscle creatine levels and may benefit from higher daily doses, particularly in women and older adults. Some clinicians are now recommending 8 to 10 grams per day for cognitive benefit, a dose that would have sounded extreme five years ago but is supported by the recent imaging studies. The cost is still negligible at standard creatine monohydrate prices.
The supplement industry has noticed. Creatine sales jumped roughly 40 percent year over year in 2025 and the same trend has continued into the first quarter of 2026. The market expansion is being driven by buyers who are not lifters. Women in their 40s and 50s, college students, and adults over 60 are now the fastest growing buyer segments according to retail data from major supplement chains. The product itself has not changed much. Creatine monohydrate is still the form with the most evidence behind it, and most of the newer formulations like creatine HCL and creatine ethyl ester do not show meaningfully better results in head to head trials. The marketing has shifted to make the supplement feel relevant to people who never considered it.
There are a few caveats worth keeping in mind. Creatine causes water retention in muscle cells, which often shows up as a one to two pound weight gain in the first week. That is intracellular water and is not weight gain in the way most people think about it, but it is enough to spook some users who quit before the supplement has a chance to work. Kidney concerns have been studied extensively and the evidence in healthy adults is consistently reassuring, though anyone with existing kidney disease should talk to a doctor first. The brain effects appear to take longer than the muscle effects, with most studies showing changes in brain creatine levels after four to eight weeks of consistent use.
The longer term picture is that creatine is moving into the same category as fish oil and vitamin D. A supplement that started as a niche product for a specific population, accumulated enough research over decades to be considered safe and effective, and slowly broke into mainstream use as evidence accumulated for non original use cases. The price is still cheap, the safety profile is still solid, and the research keeps adding new applications. Whether creatine ends up being a routine part of how Americans think about cognitive aging the way fish oil is now part of how they think about heart health is the question the next five years will answer. The CONCRET MENOPA results suggest the answer is probably yes.